Retrospective Study of Combination Chemotherapy With Etoposide and Ifosfamide in Patients With Heavily Pretreated Recurrent or Persistent Epithelial Ovarian Cancer
Abstract:Objective This retrospective study is to evaluate the efficacy and toxicity of combination chemotherapy with etoposide and ifosfamide (ETI) in the management of pretreated recurrent or persistent epithelial ovarian cancer (EOC). Methods Patients with recurrent or persistent EOC who had measurable disease and at least one chemotherapy regimen were to receive etoposide at a dose of 100 mg/m 2 /day intravenous (IV) on days 1 to 3 in combination with ifosfamide 1 g/m 2 /day IV on days 1 to 5, every 21 days. Result… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.